A multicenter, randomized, double-blind, placebo-controlled, parallel study to investigate the efficacy and safety of multiple oral doses of tasimelteon and matching placebo in travelers with Jet Lag Disorder
Phase of Trial: Phase III
Latest Information Update: 25 Apr 2016
At a glance
- Drugs Tasimelteon (Primary)
- Indications Circadian rhythm sleep disorders; Jet lag
- Focus Therapeutic Use
- Sponsors Vanda Pharmaceuticals
- 25 Apr 2016 Status changed from planning to recruiting.
- 10 Feb 2016 According to a Vanda Pharmaceuticals media release, this study is expected to begin in the second half of 2016.
- 03 Nov 2015 According to a Vanda Pharmaceuticals media release, this study is expected to begin in the first quarter of 2016.